Stock Report

Aspira Pathlab and Diagnostics Ltd posts Rs. 1.44 crore profit in Q4FY22

Posted On : 2022-05-30 14:38:45( TIMEZONE : IST )

Aspira Pathlab & Diagnostics Limited has reported Standalone financial results for the period ended March 31, 2022.

Financial Results (Q4 FY2022) - QoQ Comparison

The company has reported total income of Rs. 5.4767 crores during the period ended March 31, 2022 as compared to Rs. 4.7482 crores during the period ended December 31, 2021.

The company has posted net profit / (loss) of Rs. 1.4428 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs. 0.8694 crores for the period ended December 31, 2021.

The company has reported EPS of Rs. 1.52 for the period ended March 31, 2022 as compared to Rs. 0.84 for the period ended December 31, 2021.

Financials	Q4 FY2022	Q3 FY2022	% Change
Total Income	₹ 5.4767 crs	₹4.7482 crs	15.34%
Net Profit	₹1.4428 crs	₹0.8694 crs	65.95%
EPS	₹1.52	₹0.84	80.95%

Financial Results (Q4 FY2022) - YoY Comparison

The company has reported total income of Rs. 5.4767 crores during the period ended March 31, 2022 as compared to Rs.4.1249 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.1.4428 crores for the period ended March 31, 2022 as against net profit / (loss) of Rs.0.4282 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.1.52 for the period ended March 31, 2022 as compared to Rs.0.59 for the period ended March 31, 2021.

Financials	Q4 FY2022	Q4 FY2021	% Change
Total Income	₹ 5.4767 crs	₹4.1249 crs	32.77%
Net Profit	₹1.4428 crs	₹0.4282 crs	236.95%
EPS	₹1.52	₹0.59	157.63%

Financial Results (Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.19.6448 crores during the Financial Year ended March 31, 2022 as compared to Rs.15.4092 crores during the Financial Year ended March 31, 2021.

The company has posted net profit / (loss) of Rs.4.4594 crores for the Financial Year ended March 31, 2022 as against net profit / (loss) of Rs.1.3810 crores for the Financial Year ended March 31, 2021.

The company has reported EPS of Rs.4.33 for the Financial Year ended March 31, 2022 as compared to Rs.1.45 for the Financial Year ended March 31, 2021.

Financials	Year Ended FY2022	Year Ended FY2021	% Change
Total Income	₹19.6448 crs	₹15.4092 crs	27.49%
Net Profit	₹4.4594 crs	₹1.3810 crs	222.91%
EPS	₹4.33	₹1.45	198.62%

Shares of Aspira Pathlab & Diagnostics Limited was last trading in BSE at Rs. 54.95 as compared to the previous close of Rs. 53.50. The total number of shares traded during the day was 279 in over 4 trades.

The stock hit an intraday high of Rs. 54.95 and intraday low of 53.50. The net turnover during the day was Rs. 15231.00.